Urinary excretion of dimethyltryptamine in liver disease
Checkley, S.A.; Oon, M.C.; Rodnight, R.; Murphy, M.P.; Williams, R.S.; Birley, J.L.
American Journal of Psychiatry 136(4a): 439-441
1979
ISSN/ISBN: 0002-953X PMID: 284722 Document Number: 4855
The urinary excretion of N,N-dimethyltryptamine (DMT) was higher in patients with severe liver disease than in normal subjects. This difference remained significant when patients with all grades of hepatic encephalopathy were excluded. Patients with liver disease whose mental states were normal excreted amounts of DMT similar to those of patients with a hospital diagnosis of schizophrenia.
Document emailed within 1 workday
Related Documents
Matsumoto, H.; Pietruszewska, I. 1978: Urinary excretion of bufotenin, N,N-dimethyltryptamine and 3,4-dimethoxyphenylethylamine and the clinical picture of mental disorders Psychiatria Polska 12(2): 189-197Ostrowski, J. 1985: Urinary excretion of porphyrins and their precursors in chronic liver disease Materia Medica Polona. Polish Journal of Medicine and Pharmacy 17(4): 240-245
Ichiba, M.; Yamada, S.; Ishii, K.; Gonda, K.; Murai, R.; Shimomura, T.; Saeki, T.; Kanbe, T.; Tanabe, Y.; Yoshida, Y.; Tsuchiya, H.; Hoshikawa, Y.; Kurimasa, A.; Kishimoto, Y.; Kawasaki, H.; Shiota, G. 2007: Significance of urinary excretion of 8-hydroxy-2'-deoxyguanosine in healthy subjects and liver disease patients Hepato-Gastroenterology 54(78): 1736-1740
Rector, W.G. 1987: Urinary prostaglandin E2 excretion, sodium retention, and diuretic responsiveness in patients with chronic liver disease American Journal of Gastroenterology 82(4): 347-351
Minami, M.; Togashi, H.; Sano, M.; Yoshioka, M.; Saito, I.; Morii, K.; Tochihara, M.; Hirogami, M.; Nomura, A.; Saito, H. 1985: Effects of new antihypertensive agent, 2-[4-(n-butyryl)-homopiperazine-1-ul]-4-amino-6, 7-dimethoxy-quinazoline (E-643), on blood pressure, urinary sodium excretion and urinary norepinephrine excretion rate in stroke-prone, spontaneously hypertensive rats Hokkaido Journal of Medical Science 60(4): 536-543
Kaznacheev, V.P.; Gichev, I.P.; Korobkova, E.N. 1972: Urinary excretion of hydroxyproline in patients with chronic hepatitis and liver cirrhosis Terapevticheskii Arkhiv 44(3): 20-24
Szpakowicz, T. 1980: Diurnal urinary excretion of serotonin and 5-hydroxyindoleacetic acid in chronic liver diseases Polski Tygodnik Lekarski 35(3): 77-79
Chernyshov, V.G. 1973: Urinary excretion of 17-hydroxycorticosteroids and 17-ketosteroids in acute and chronic liver diseases under cortisone load Problemy Endokrinologii 19(3): 22-25
Wang Lu, L.J.; Demetriou, S.K.; Domino, E.F. 1978: Effects of various neuroleptics, phenobarbital and SKF 525-A on dimethyltryptamine content in rat brain and liver Archives Internationales de Pharmacodynamie et de Therapie 232(1): 117-133
Schreiber, V.; Tomsová, Z.; Límanová, Z.; Jůzová, Z. 1989: Increased urinary excretion of neopterin in patients with Graves-Basedow disease Casopis Lekaru Ceskych 128(28): 883-884
Polhuijs, M.; Meijer, D.K.; Mulder, G.J. 1991: The fate of diastereomeric glutathione conjugates of alpha-bromoisovalerylurea in blood in the rat in vivo and in the perfused liver. Stereoselectivity in biliary and urinary excretion Journal of Pharmacology and Experimental Therapeutics 256(2): 458-461
Adenskiĭ, A.D.; Mostovaia, S.A. 1970: Effect of hypothiazide on the urinary excretion of uric acid in patients with hypertensive disease Kardiologiia 10(9): 120-121
Wibell, L. 1978: The serum level and urinary excretion of beta2-microglobulin in health and renal disease Pathologie-Biologie 26(6): 295-301
Przybyszowski, A.; Lejman, W.; Adamczyk, B. 1979: Urinary creatine and creatinine excretion in patients with Cushing's disease treated by adrenalectomy Polski Przeglad Chirurgiczny 51(2): 161-166
Streifler, M.; Vardi, Y.; Kesten, M.; Oberman, Z.; Herzberg, M. 1972: Urinary excretion of dopamine and homovanillic acid during L-dopa treatment of Parkinson's disease Israel Journal of Medical Sciences 81(5): 597-601
Romero-Vecchione, E.; Vásquez, J.; Lema, G.; Guerrero, H.; Rosa, F.; Bermúdez, M. 1995: Low urinary dopamine excretion associated to low sodium excretion in normotensive Piaroa Amazonian ethnia compared to urban subjects Investigacion Clinica 36(2): 61-71
Aslanian, N.L.; Babaian, L.A.; Kurginian, A.G.; Shukhian, V.M. 1984: Dietary intake and urinary excretion of various mineral substances in patients with hypertension and ischemic heart disease Voprosy Pitaniia 2: 16-19
Blumenkrantz, N.; Asboe-Hansen, G. 1980: Variation of urinary acid glycosaminoglycan and collagen metabolite excretion with disease activity in generalized scleroderma Acta Dermato-Venereologica 60(1): 39-43
Mandel, L.R. 1974: Dimethyltryptamine: its biosynthesis and possible role in mental disease Psychopharmacology Bulletin 10(3): 55-56
Mäurer, W.; Yoshida, Y.; Kübler, W. 1976: Urinary excretion of the catecholamines adrenaline, noradrenaline and dopamine as well as the derivatives metanephrine and normetanephrine in heart disease patients Zeitschrift für Kardiologie 65(12): 1124-1138